Last updated on August 2018

Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors


Brief description of study

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely when it is used together with the chemotherapy drug Cyclophosphamide.

Clinical Study Identifier: NCT02013336

Contact Investigators or Research Sites near you

Start Over

Susan Heavner

University Of Oklahoma Health Sciences Center
Oklahoma City, OK United States
  Connect »

Alison Patterson

UT Southwestern
Dallas, TX United States
  Connect »

Amanda Knight, RN, BSN, CCRP

Texas Tech University Health Sciences Center
Lubbock, TX United States
  Connect »

Adam Fiebelkorn

Midwest Children's Hospital
Milwaukee, WI United States
  Connect »

Joseph Pressey, MD

Cincinnati Children's Hospital Medical Center
Cincinnati, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.